Moolec Science (MLEC) Stock Price, News & Analysis

Company Overview

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.

Key Stats

• Today's Range: $0.77 to $0.81
• 50-Day Range: $0.76 to $0.93
• 52-Week Range: $0.75 to $3.25
• Volume: 11,317 shs
• Average Volume: 13,785 shs
• Market Capitalization: $30.41 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $6.00
• Consensus Rating: Buy

Moolec Science Stock Analysis - MarketRank™

Moolec Science scored higher than 38% of companies evaluated by MarketBeat, and ranked 116th out of 147 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Moolec Science has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Moolec Science has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Moolec Science is -3.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Moolec Science is -3.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Moolec Science has a P/B Ratio of 4.39. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.38% of the float of Moolec Science has been sold short.

Short Interest Ratio / Days to Cover

Moolec Science has a short interest ratio ("days to cover") of 5.3.

Change versus previous month

Short interest in Moolec Science has recently decreased by 7.93%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Moolec Science does not currently pay a dividend.

Dividend Growth

Moolec Science does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.38% of the float of Moolec Science has been sold short.

Short Interest Ratio / Days to Cover

Moolec Science has a short interest ratio ("days to cover") of 5.3.

Change versus previous month

Short interest in Moolec Science has recently decreased by 7.93%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Moolec Science this week, compared to 0 articles on an average week.

Search Interest

1 people have searched for MLEC on MarketBeat in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Moolec Science insiders have not sold or bought any company stock.

Percentage Held by Insiders

19.90% of the stock of Moolec Science is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 0.07% of the stock of Moolec Science is held by institutions.

MLEC Stock Analysis - Frequently Asked Questions

How have MLEC shares performed this year?

Moolec Science's stock was trading at $0.80 on January 1st, 2025. Since then, MLEC shares have decreased by 1.1% and is now trading at $0.7910.
View the best growth stocks for 2025 here.

How were Moolec Science's earnings last quarter?

Moolec Science SA (NASDAQ:MLEC) issued its earnings results on Wednesday, October, 2nd. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.06) by $0.01. The company had revenue of $1.52 million for the quarter. Moolec Science had a negative net margin of 129.97% and a negative trailing twelve-month return on equity of 97.95%.

How do I buy shares of Moolec Science?

Shares of MLEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Moolec Science own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Moolec Science investors own include PayPal (PYPL), TriNet Group (TNET), Tesla (TSLA), ABM Industries (ABM), Adverum Biotechnologies (ADVM), APi Group (APG) and Avino Silver & Gold Mines (ASM).

Company Calendar

• Last Earnings: 10/02/2024
• Today: 1/21/2025
• Next Earnings (Estimated): 3/11/2025
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Staples
• Industry: Holding & other investment offices
• Sub-Industry: Trading
• Current Symbol: NASDAQ:MLEC
• CUSIP: N/A
• CIK: 1937737
• Web: moolecscience.com
• Phone: 650-515-3930
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $6.00
• High Stock Price Target: $6.00
• Low Stock Price Target: $6.00
• Potential Upside/Downside: +658.5%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.20)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-7,310,000.00
• Net Margins: -129.97%
• Pretax Margin: -148.60%
• Return on Equity: -97.95%
• Return on Assets: -27.91%

Debt

• Debt-to-Equity Ratio: 1.75
• Current Ratio: 1.69
• Quick Ratio: 0.92

Sales & Book Value

• Annual Sales: $5.62 million
• Price / Sales: 5.41
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.18 per share
• Price / Book: 4.39

Miscellaneous

• Outstanding Shares: 38,440,000
• Free Float: 30,791,000
• Market Cap: $30.41 million
• Optionable: Not Optionable
• Beta: -0.47